Suzhou CureMed Biopharma Technology Co., Ltd
PrivateLast Round
Series C
May 16, 2025
Est. Valuation
$416.36M
Total Funding Raised
$20.88M
Company Overview
Suzhou CureMed Biopharma Technology Co., Ltd is a biopharmaceutical company that develops circular mRNA nucleic acid drugs and LNP delivery systems for infectious diseases, oncology, and gene therapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou CureMed Biopharma Technology Co., Ltd Comparables
Compare Suzhou CureMed Biopharma Technology Co., Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RiboX Therapeutics | 86% | |
| Immorna Biotherapeutics | 85% | |
| Abogen Biosciences | 83% | |
Suzhou CureMed Biopharma Technology Co., Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 16, 2025 | ||||
| Strategic | Apr 27, 2025 | ||||
| Series B | Apr 2, 2024 | ||||
| Series A | May 27, 2022 |
Suzhou CureMed Biopharma Technology Co., Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen New Industry Venture Capital | Series B |
| Bin Zayed Group | Strategic |
| HongShan Capital Group (HSG) | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2025
$21M round completed.
- Apr 27, 2025
Bin Zayed Group led the strategic round.
Suzhou CureMed Biopharma Technology Co., Ltd Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Suzhou CureMed Biopharma Technology Co., Ltd's valuation, stock price, and market status.